S. Heikkinen-t, D. Barrowdale, K. Pylkäs, J. Roberts, D. Subramanian et al., Breastcancer risk in families with mutations in PalB2, N Engl J Med, vol.371, pp.497-506, 2014.

D. F. Easton, P. D. Pharoah, M. Tavtigian, S. V. Nathanson-kl, P. Devilee et al., chenevix-trench g, rahman n, robson M, Domchek SM, Foulkes WD. gene-panel sequencing and the prediction of breast-cancer risk, N Engl J Med, vol.372, pp.2243-57, 2015.

M. Desmond-a,-kurian-aw,-gabree, M. Ma, A. Mj, Y. Kobayashi, . Horick-n et al., ellisen lW. clinical actionability of Multigene Panel testing for Hereditary Breast and Ovarian cancer risk assessment, JAMA Oncol, vol.1, pp.943-51, 2015.

O. Pagani, . Partridge-ah, and J. Garber, time to incorporate germline multigene panel testing into breast and ovarian cancer patient care, Breast Cancer Res Treat, vol.160, pp.393-410, 2016.

M. B. Daly, P. R. Berry, M. Buys, S. S. Farmer, M. Friedman et al., nccn guidelines insights: genetic/Familial High-risk assessment: Breast and Ovarian, Version 2, Journal of the National Comprehensive Cancer Network, vol.15, pp.9-20, 2017.

D. M. Eccles, M. G. Monteiro-an, . Schmutzler-r, and F. J. Couch, Spurdle aB, gómez-garcía eB. enigMa clinical Working group. Brca1 and Brca2 genetic testingpitfalls and recommendations for managing variants of uncertain clinical significance, Ann Oncol, vol.26, pp.2057-65, 2015.

S. Richards, S. Bale, D. Bick, S. Das, J. Gastier-foster et al., acMg laboratory Quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of Medical genetics and genomics and the association for Molecular Pathology, Genet Med, vol.17, pp.405-428, 2015.

M. Colombo, M. J. Blok, P. Whiley, M. Santamariña, S. Gutiérrez-enríquez et al., Spurdle aB, radice P, De la Hoya M. kconFaB investigators. comprehensive annotation of splice junctions supports pervasive alternative splicing at the Brca1 locus: a report from the enigMa consortium, Hum Mol Genet, vol.23, pp.3666-80, 2014.

J. D. Fackenthal, Y. T. Zhang, B. , M. , D. Vecchi-g et al., Spurdle aB, radice P, de la Hoya M. kconFaB investigators. naturally occurring Brca2 alternative mrna splicing events in clinically relevant samples, J Med Genet, vol.53, pp.548-58, 2016.

V. Dosil, P. Pérez-segura, and . Díaz-rubio-e, de la Hoya M. alternative splicing and molecular characterization of splice site variants: Brca1 c.591c>t as a case study, Clin Chem, vol.56, pp.53-61, 2010.

M. De-la-hoya, O. Soukarieh, . López-perolio-i, . Vega-a, . Walker et al., Spurdle aB. combined genetic and splicing analysis of Brca1 c, Hum Mol Genet, vol.25, pp.2256-68, 2016.

. Davy-g, V. Harter, F. R. Muller-e, B. Brault, F. Smirnova-as,-lemoine et al., Detecting splicing patterns in genes involved in hereditary breast and ovarian cancer, Eur J Hum Genet, vol.25, pp.1147-54, 2017.

, Human gc-ag alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions, Nucleic Acids Res, vol.29, pp.2581-93, 2001.

M. A. Kim-e, Different levels of alternative splicing among eukaryotes, Nucleic Acids Res, vol.35, pp.125-156, 2007.

S. Djebali, J. Davis-ca, W. Lin, F. Schlesinger, X. C. Marinov-gk et al., Nature, vol.489, pp.101-109, 2012.

B. J. Blencowe, alternative splicing: new insights from global analyses, Cell, vol.126, pp.37-47, 2006.

F. Tress-ml and V. A. , Most alternative isoforms are not Functionally important, Trends Biochem Sci, vol.42, pp.408-418, 2017.

B. J. Blencowe, the relationship between alternative Splicing and Proteomic complexity, Trends Biochem Sci, vol.42, pp.407-415, 2017.

K. J. Niklas, B. Se, . Dunker-ak, and S. Newman, rethinking gene regulatory networks in light of alternative splicing, intrinsically disordered protein domains, and posttranslational modifications, Front Cell Dev Biol, vol.3, p.8, 2015.

P. J. Whiley, M. De-la-hoya, M. Becker-a, . Brandão-r,-pedersen-is, M. Montagna et al., Clin Chem, vol.60, pp.341-52, 2014.

J. Wong-em, H. Ma, and . Jl, Brown Ma, chenevix-trench g, Spurdle aB, Southey Mc. kconFab. Molecular characterization and cancer risk associated with Brca1 and Brca2 splice site variants identified in multiple-case breast cancer families, Hum Mutat, vol.26, p.495, 2005.

M. H. Nieuwenhuis and H. F. Vasen, correlations between mutation site in aPc and phenotype of familial adenomatous polyposis (FaP): a review of the literature, Crit Rev Oncol Hematol, vol.61, pp.153-61, 2007.

. Rosenthal, . Bowles-kr, D. Pruss, . Van-kan-a, P. J. Vail et al., exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes, Clin Genet, vol.88, pp.533-574, 2015.

J. Y. Park, F. Zhang, and P. Andreassen, PalB2: the hub of a network of tumor suppressors involved in Dna damage responses, Biochim Biophys Acta, vol.1846, pp.263-75, 2014.

J. M. Mudge, . Frankish-a, J. Fernandez-banet, D. T. Howald-c, and . Hubbard, Harrow J. the origins, evolution, and functional potential of alternative splicing in vertebrates, Mol Biol Evol, vol.28, pp.2949-59, 2011.

P. J. Byrd, . Stewart-gs, . Smith, P. Fooks, J. Last et al., Stankovic t, taylor aM. a Hypomorphic PalB2 allele gives rise to an Unusual Form of Fa-n associated with lymphoid tumour Development, PLoS Genet, vol.12, p.1005945, 2016.